Budget Impact Analysis Of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week For Cancer Patients Receiving Chemotherapy From A Us Payer's Perspective
May 1, 2013, 00:00
10.1016/j.jval.2013.03.639
https://www.valueinhealthjournal.com/article/S1098-3015(13)00710-9/fulltext
Title :
Budget Impact Analysis Of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week For Cancer Patients Receiving Chemotherapy From A Us Payer's Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00710-9&doi=10.1016/j.jval.2013.03.639
First page :
A131
Section Title :
Cancer
Open access? :
No
Section Order :
187